These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 16964591)

  • 1. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
    Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
    Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.
    Durandy A; Revy P; Imai K; Fischer A
    Immunol Rev; 2005 Feb; 203():67-79. PubMed ID: 15661022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
    Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
    J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
    Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
    Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.
    Imai K; Slupphaug G; Lee WI; Revy P; Nonoyama S; Catalan N; Yel L; Forveille M; Kavli B; Krokan HE; Ochs HD; Fischer A; Durandy A
    Nat Immunol; 2003 Oct; 4(10):1023-8. PubMed ID: 12958596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID.
    Wakae K; Magor BG; Saunders H; Nagaoka H; Kawamura A; Kinoshita K; Honjo T; Muramatsu M
    Int Immunol; 2006 Jan; 18(1):41-7. PubMed ID: 16291656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory.
    Muramatsu M; Nagaoka H; Shinkura R; Begum NA; Honjo T
    Adv Immunol; 2007; 94():1-36. PubMed ID: 17560270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
    Péron S; Pan-Hammarström Q; Imai K; Du L; Taubenheim N; Sanal O; Marodi L; Bergelin-Besançon A; Benkerrou M; de Villartay JP; Fischer A; Revy P; Durandy A
    J Exp Med; 2007 May; 204(5):1207-16. PubMed ID: 17485519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AID mutant analyses indicate requirement for class-switch-specific cofactors.
    Ta VT; Nagaoka H; Catalan N; Durandy A; Fischer A; Imai K; Nonoyama S; Tashiro J; Ikegawa M; Ito S; Kinoshita K; Muramatsu M; Honjo T
    Nat Immunol; 2003 Sep; 4(9):843-8. PubMed ID: 12910268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
    Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
    Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AID enzyme induces class switch recombination in fibroblasts.
    Okazaki IM; Kinoshita K; Muramatsu M; Yoshikawa K; Honjo T
    Nature; 2002 Mar; 416(6878):340-5. PubMed ID: 11875397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AID-initiated purposeful mutations in immunoglobulin genes.
    Goodman MF; Scharff MD; Romesberg FE
    Adv Immunol; 2007; 94():127-55. PubMed ID: 17560274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AID targeting in antibody diversity.
    Pavri R; Nussenzweig MC
    Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
    Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
    Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apex2 is required for efficient somatic hypermutation but not for class switch recombination of immunoglobulin genes.
    Sabouri Z; Okazaki IM; Shinkura R; Begum N; Nagaoka H; Tsuchimoto D; Nakabeppu Y; Honjo T
    Int Immunol; 2009 Aug; 21(8):947-55. PubMed ID: 19556307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.